(Q37070216)

18 August 2017

1 reference

title

Technology Insight: biomarker development in acute kidney injury--what can we anticipate? (English)

1 reference

18 August 2017

0 references

3

Mark D Okusa

1 reference

18 August 2017

4

Jonathan Himmelfarb

1 reference

18 August 2017

Bruce A Molitoris

1

1 reference

PubMed ID

18227821

18 August 2017

Vyacheslav Y Melnikov

series ordinal

2

1 reference

PubMed ID

18227821

18 August 2017

language of work or name

1 reference

29 January 2008

1 reference

Nature Clinical Practice Nephrology

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

3

1 reference

18 August 2017

154-165

1 reference

Assessing the generalizability of prognostic information

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

Diagnosis and treatment of acute tubular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Community-based incidence of acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Mortality after acute renal failure: models for prognostic stratification and risk adjustment

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

A clinical score to predict acute renal failure after cardiac surgery.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Pulmonary artery catheter versus pulse contour analysis: a prospective epidemiological study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Biomarkers of cardiovascular disease: molecular basis and practical considerations

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

The US Food and Drug Administration perspective on cancer biomarker development.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Statistical validation of intermediate endpoints for chronic diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Issues in clinical trial design for tumor marker studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

A guide for reviewing submitted manuscripts (and indications for the design of translational research studies on biomarkers)

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Multiple biomarkers for the prediction of first major cardiovascular events and death

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Prior restraint: a Bayesian perspective on the optimization of technology utilization for diagnosis of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Validation, calibration, revision and combination of prognostic survival models

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

A review of goodness of fit statistics for use in the development of logistic regression models

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Biomarkers in cancer staging, prognosis and treatment selection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Cardiovascular biomarkers: added value with an integrated approach?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

1 reference

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

An integrated approach to prognosis using protein microarrays and nonparametric methods

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

The roles of multiple proteomic platforms in a pipeline for new diagnostics

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Cancer biomarkers--an invitation to the table

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

The rocky road to useful cancer biomarkers

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Issues and barriers to development of clinically useful tumor markers: a development pathway proposal

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Rules of evidence for cancer molecular-marker discovery and validation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Drinking from the fire hose--statistical issues in genomewide association studies.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

The incidentalome: a threat to genomic medicine

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Lessons from controversy: ovarian cancer screening and serum proteomics.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Acute kidney injury prediction following elective cardiac surgery: AKICS Score

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Cytokine gene promoter polymorphisms and mortality in acute renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Early detection of acute renal failure by serum cystatin C.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Modified RIFLE criteria in critically ill children with acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): Targeting the Problem with the RIFLE Criteria

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Acute renal failure after cardiac surgery: evaluation of the RIFLE classification

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

1 reference

7 January 2021

Biomarkers for the early detection of acute kidney injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Discovery of protein biomarkers for renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Renal L-type fatty acid--binding protein in acute ischemic injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Differential gene expression following early renal ischemia/reperfusion.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Global analysis of gene expression in renal ischemia-reperfusion in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Early prediction of acute renal injury using urinary proteomics

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Metabolomic study of cisplatin-induced nephrotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Urine biomarkers predict the cause of glomerular disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0723

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0723

1 reference

18 August 2017

1 reference

PubMed ID

18227821